Meatpacker JBS to close U.S. plant-based foods business
Reuters
Published Oct 03, 2022 12:30PM ET
Updated Oct 03, 2022 04:57PM ET
By Tom Polansek
CHICAGO (Reuters) -Brazilian meatpacker JBS SA (OTC:JBSAY) is closing its U.S. plant-based foods business, Planterra Foods, after about two years, the company said on Monday.
The closure signals increasing troubles in the plant-based protein sector, where U.S. sales are flattening.
Colorado-based Planterra sold fake meat under the Ozo brand, but JBS will now focus on its plant-based operations in Brazil and Europe, said Nikki Richardson, spokesperson for JBS USA. European and Brazilian operations "continue to gain market share and expand their respective customer bases," she said.
The sector has come under pressure because meat alternatives do not taste good enough and prices are too high, said Gary Stibel, chief executive of the New England Consulting Group, which works on consumer products. He said JBS made a good decision to shut Planterra.
"Everybody and her sister thinks they can make money in this business and they can't," Stibel said. "Eventually it will be a good business for a few players. Today, it is a sinkhole for many folks that are throwing good money after bad, chasing too little demand with way too much supply."
This summer, Beyond Meat (NASDAQ:BYND) Inc lowered its revenue forecast for the year and announced job cuts as rising inflation hurt efforts to make its pricier plant-based meat more affordable.
Separately, Canadian pork processor Maple Leaf Foods has reduced the size of its plant-based business, Greenleaf Foods, by 25%.
The value of all meat alternatives sold in the United States - including fresh and fully cooked products and faux seafood – rose by 1.1% in the year ending Aug. 27 to about $963 million, NielsenIQ said. That compared to growth of 8.1% over the same period in 2021 and 44.8% in that period in 2020.
For fresh meat alternatives, U.S. sales dropped by 6.8% in the year ending Aug. 27 to about $254 million, compared to a year earlier, NielsenIQ said. Sales in the category climbed 28.9% over that same period from 2020 to 2021.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.